{
  "$schema": "folio-library-entry/v1",
  "id": "10665-266751",
  "blocks": [
    {
      "id": "library/10665-266751/blocks/prose-sec-front-matter",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Front matter",
      "pageStart": 1,
      "pageEnd": 3,
      "target": "../sections/sec-front-matter.md",
      "narrative": null,
      "content": "Bull. Org. mond. Sante\nBull. Wld Hith Org.\nj\nPossibilites d'amelioration des vaccins anticholeriques\net methodes d'evaluation de leur efficacite\nLOUIS DELPY,1 Dr Vet.\nLes doutes qui planent sur la valeur protectrice des vaccins anticholriques proviennent\nde diffierences importantes dans l'activite' immunisante de lots apparemment identiques. Ces\ndifferences ontpour cause l'insuffisance des titrages, et des techniques de preparation basees\nsur une conception errone'e du mode d'action des vaccins tue's.\nL'aptitude des vaccins anticholeriques a crder l'immunite ne peut e'tre mesure'e que par\ndes",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The opening of a French Bulletin article by Louis Delpy on improving cholera vaccines and assessing their efficacy, whose abstract argues that uneven protection comes from poor titration and from preparation methods based on a wrong view of how killed vaccines work. It states that protection depends on the amount of bacterial lysis products, not on counts of fixed bacteria, and proposes vaccines made from stabilized autolysates. The text then reviews natural immunity after cholera, which rarely lasts beyond six months, and stresses that antibodies detectable in vitro do not necessarily indicate protection.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266751/blocks/prose-sec-000",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Un",
      "pageStart": 3,
      "pageEnd": 3,
      "target": "../sections/sec-000-un.md",
      "narrative": null,
      "content": "correlation entre ces deux ordres de phenomenes est\ndans certains cas possible, mais elle ne peut etre\nconsideree comme certaine que si elle a ete experi-\nmentalement constatee dans chaque cas particulier.\nLa meconnaissance, innocente ou deliberee, de ces\nfaits bien etablis, est responsable de l'utilisation par-\nfois obligatoire de vaccins dont le pouvoir immuni-\nsant, c'est-'a-dire protecteur, est nul.\nEn ce qui concerne le cholera, la correlation entre\nla presence, dans le serum, d'agglutinines- ou autres\nanticorps decelables in vitro et l'existence de l'etat\nrefractaire n'a jamais ete demon",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Argues that a link between serum agglutinins and resistance to cholera has never been shown, and that ignoring this has led to the use of vaccines with no protective power.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266751/blocks/prose-sec-001",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "minee",
      "pageStart": 3,
      "pageEnd": 3,
      "target": "../sections/sec-001-minee.md",
      "narrative": null,
      "content": "exceptions etant admises, il est dangereux et injustifie\nd'attendre des epreuves serologiques des renseigne-\nments qu'elles ne sauraient fournir.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Concludes that it is risky to expect serological tests to show what they cannot reveal about cholera vaccine potency.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266751/blocks/prose-sec-002",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Quant",
      "pageStart": 3,
      "pageEnd": 4,
      "target": "../sections/sec-002-quant.md",
      "narrative": null,
      "content": "a\nla numeration\ndes\ncorps\nde\nVibrio\ncholerae presents dans un vaccin stabilise,\nil sera\nmontre plus loin qu'elle n'a en soi aucune significa-\ntion parce que les vibrions fixes et refractaires 'a la\nlyse n'ont qu'un r6le nul ou tres faible dans la pro-\nduction de l'immunite protectrice.\nPar consequent, pour pouvoir evaluer au labora-\ntoire le pouvoir immunisant du vaccin antichole-\nrique, comme celui des autres vaccins bacteriens\ntues, il est necessaire d'avoir recours 'a des epreuves\nde protection active d'animaux d'experience.\nEpreuves de protection active des animaux\nde laboratoire\nLa seule",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that counting vibrios in a vaccine says little about its potency, so active protection tests in laboratory animals are needed. It describes the mouse protection test and its variants by Burrows and by Sokhey and Habbu, and compares results from the two methods. The block ends by noting that oral infection of animals gives antibacterial effects in the gut that better resemble human infection.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266751/blocks/prose-sec-003",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Nos",
      "pageStart": 4,
      "pageEnd": 4,
      "target": "../sections/sec-003-nos.md",
      "narrative": null,
      "content": "connaissances\nsur\nl'immunite\nactive\nde\nl'homm- contre le cholera, que cette immunite soit\nnaturelle ou artificielle, sont tres insuffisantes. Les\nepreuves de protection des animaux de laboratoire,\nqui constituent le seul procede de mesure des pro-\nprietes protectrices des vaccins, donnent des resul-\ntats difficilement comparables en raison de la diver-\nsite des techniques employees. Les normes proposees\npar l'OMS (1959) comportent la comparaison des\nvaccins sous contr6le a un vaccin de reference, ce\nqui doit supprimer dans une certaine mesure l'effet\ndes variables introduites dans les epreuves",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Notes that knowledge of human cholera immunity is poor and that animal protection tests vary too much to compare, though WHO standards call for a reference vaccine. It points out that peritoneal infection of animals differs from intestinal infection in humans, and that small producers may not test every lot.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266751/blocks/prose-sec-004",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "CONSTITUTION ET MODE D'ACTION DES VACCINS TUtS",
      "pageStart": 4,
      "pageEnd": 7,
      "target": "../sections/sec-004-constitution-et-mode-daction-des-vaccins-tuts.md",
      "narrative": null,
      "content": "VACCINS TUES FIGURES\nL'injection d'un vaccin tue provoque l'apparition\ndans le serum de divers anticorps, mais la plupart\nd'entre eux n'ont aucun role dans la constitution de\nl'immunite protectrice.\nII est probable qu'un jour\nl'immunochimie permettra de reconnaitre et d'isoler\nles constituants des cellules microbiennes qui se\ncomportent en antigenes protecteurs. Actuellement,\nnos connaissances sont incompletes\net deconcer-\ntantes: ni la constitution chimique, ni la localisation\ndans la cellule bacterienne ne permettent de diff&\nrencier les antigenes protecteurs des autres. Ce qui\nest vrai pour",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that most killed vaccines are suspensions of bacteria fixed by heat or antiseptics, which resist lysis and give irregular immunity. It reviews lysed vaccines prepared by chemical, physical or biological means and argues that protective antigens lie inside as well as on the surface of bacteria. Evidence from other bacteria such as Pasteurella septica is used to show that autolysis products carry protective power.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266751/blocks/prose-sec-005",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Dans",
      "pageStart": 7,
      "pageEnd": 8,
      "target": "../sections/sec-005-dans.md",
      "narrative": null,
      "content": "nant ces bacteries, n'a permis de penser que les\nantigenes protecteurs\nsont\nlocalises a la surface\nexteme et non dans le cytoplasme. La remarque faite\nprece'demment au sujet de I'aptitude autolytique de\nla souche S. typhi Ty 58, et d'autres observations du\nmeme ordre tendent 'a prouver le contraire.\nOBSERVATIONS CONCERNANT SPECIALEMENT\nLES VACCINS ANTICHOLERIQUES\nClassification des vaccins actuellement en usage\nLes\nvaccins\ninjectables\npar\nvoie\nparenterale\npeuvent etre divises en deux groupes, d'apres la\ntechnique de culture des vibrions:\nA.\nType Kolle (1896). Suspensions titrees et ste-\nrilise",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Classifies cholera vaccines in use by culture method (agar-grown Kolle type or liquid-grown Sokhey and Habbu type) and by composition, from fixed whole cells to fully lysed products. It explains how delays and temperature before sterilization allow hidden autolysis that raises potency without changing the bacterial count. It cites Pollitzer's discussion of vaccine keeping qualities and turns to studies of autolysates against cholera.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266751/blocks/prose-sec-006",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "humain",
      "pageStart": 8,
      "pageEnd": 8,
      "target": "../sections/sec-006-humain.md",
      "narrative": null,
      "content": "des\nautolysats proprement\ndits n'a\nfait\nl'objet\nque\nde\nrares\nrecherches.\nHetsch\n(1912)\nrappelle d'anciennes experiences, qui prouvent le\npouvoir immunisant de filtrats de vieilles cultures.\nPollitzer (p. 328) cite des experiences analogues de\nStrong (1903), Bertarelli (1905), Besredka & Golo-\nvanoff (1923). Le pouvoir immunisant de vieilles\nsuspensions autolysees de V. cholerae a ete constate\npar Gohar (1934). Raju (1930), Maitra & Ahuja\n(1932), Taylor, Ahuja & Singh (1936), Ranta &\nMcCreery (1953) ont constate que la bacteriolyse\nn'entraine pas une diminution de 1'efficacite des\nvaccins. Enfi",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Reviews earlier studies showing that autolysed or lysed cholera cultures protect without losing efficacy. It recommends a simple method of preparing autolysates with thiomersal, avoiding toxicity, and adding an adjuvant.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266751/blocks/prose-sec-007",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "CONCLUSIONS ET SUGGESTIONS",
      "pageStart": 8,
      "pageEnd": 9,
      "target": "../sections/sec-007-conclusions-et-suggestions.md",
      "narrative": null,
      "content": "PREPARATION DES VACCINS\nL'intervention de la bacteriolyse clandestine per-\nmet d'expliquer pourquoi\n1'efficacite des vaccins\nanticholeriques est tres irreguliere. Elle explique le\npouvoir immunisant plus eleve des vaccins en milieu\nliquide (directs). L'utilisation judicieuse de la bact&\nriolyse controlee doit permettre la preparation de\nvaccins efficaces et stables.\n1.\nLes souches vaccinales doivent posseder, outre\nles autres proprietes enumerees dans les normes de\nl'OMS (1959), un pouvoir autolytique eleve.\n2.\nVaccins en milieu solide (type A). Preparer les\nsuspensions de V. cholerae directem",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out conclusions on preparing cholera vaccines through controlled bacteriolysis using strains with high autolytic power, for both solid- and liquid-medium vaccines. It also lists ways to evaluate efficacy, through serology, nitrogen or antigen assays, and animal protection tests, and proposes an international programme of work.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266751/blocks/prose-sec-008",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "maximum",
      "pageStart": 9,
      "pageEnd": 9,
      "target": "../sections/sec-008-maximum.md",
      "narrative": null,
      "content": "deux;\netablir une technique standard\npr&cise.\nb) Rechercher\nles possibilites de concentrer la\nproduction dans un tres petit nombre d'instituts\nspecialement\n'quipes pour une fabrication indus-\ntrielle.\nc) Reviser les methodes de titrage in vitro et in\nvivo. Etablir une technique standard pour chaque\ntype d'epreuve.\nd) Choisir pour l'entretien et la distribution des\nsouches, pour la preparation et la distribution d'un\nvaccin de reference, et pour I'accomplissement des\nrecherches urgentes, un institut\nspecialise qui ne\nserait pas necessairement situe dans les pays ofu\nsevit le cholera.\ne) Definir",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists the rest of the proposed programme, including standardizing vaccine production and testing, concentrating production in a few institutes, a reference institute, and minimum rules for vaccination campaigns.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266751/blocks/prose-sec-009",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "SUMMARY",
      "pageStart": 9,
      "pageEnd": 10,
      "target": "../sections/sec-009-summary.md",
      "narrative": null,
      "content": "Over 60 years' experience have amply demonstrated the\nvalue of cholera vaccine\nin protecting man against\nnatural cholera infection, but statistical proof of its\nefficacy is still wanting.\nPublished statistics are often\ncriticized, but their deficiencies lie at least partly in the\ngeographic, climatic, administrative, medical and social\n1 Document de travail non publie, WHO/BS/IR/47.\nconditions that obtain at the time of cholera epidemics\nand that contribute to the persistence of cholera in certain\nareas. A vaccine may make it possible to put down an\nepidemic without its efficacy being statisti",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The English summary notes that cholera vaccine seems to protect but lacks statistical proof, and that differing expert views may reflect uneven vaccine potency. It explains that hidden autolysis makes vaccines of equal titre differ in immunogenicity and recommends stabilized autolysates with an adjuvant.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266751/blocks/prose-sec-010",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "REFIRENCES BIBLIOGRAPHIQUES",
      "pageStart": 10,
      "pageEnd": 10,
      "target": "../sections/sec-010-refirences-bibliographiques.md",
      "narrative": null,
      "content": "Adiseschan, R., Pandit, C. G. & Venkatraman, K. V.\n(1947) Indian J. med. Res., 35, 131\nBull. Calcutta Sch. trop. Med., 1958, 6, 170; 1961, 11, 30\nBurrows, W. (1953) J. infect. Dis., 92, 152\nBurrows, W. & Ware, L. L. (1953) J. infect. Dis., 92, 164\nBurrows, W. et al. (1947) J. infect. Dis., 81, 157\nDelpy, L. P. (1948) Bull. Acad. vet. Fr., 21, 207\nDelpy, L. P. & Hars, E. (1953) Bull. Acad. vet. Fr., 26, 539\nDelpy, L. P. & Hars, E. (1954) Bull. Acad. vet. Fr., 27, 265\nDelpy, L. P. & Mir Chamsy, H. (1949) C.R. Acad. Sci.\n(Paris), 228, 1768\nDelpy,\nL.\nP. & Rastegar,\nR.\n(1938)\nRev. Immunol.\n(Paris),",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A list of references for the article on cholera vaccines, citing mainly studies on cholera immunity and vaccine testing from the 1900s to 1961.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    }
  ]
}
